Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Immuron Receives FDA Approval For Travelan IND Application

Dec 23 (Reuters) - Immuron Ltd  IMC.AX :
    * IMMURON RECEIVES FDA APPROVAL FOR TRAVELAN IND APPLICATION
    * IMMURON LTD - PLANS IN PLACE TO INITIATE A HUMAN CLINICAL
TRIAL
IN 60 HEALTHY VOLUNTEERS IN USA
    * IMMURON LTD - PLANS IN PLACE TO INITIATE A HUMAN CLINICAL
TRIAL
IN 60 HEALTHY VOLUNTEERS IN USA
    * IMMURON LTD - RECRUITMENT IS PLANNED TO BE INITIATED IN 1H
2023
WITH HEADLINE RESULTS FROM CLINICAL TRIAL EXPECTED TO BE
REPORTED BY YEAR END 2023

Source text for Eikon:  ID:nGNX5P25xB 
Further company coverage:  IMC.AX 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Immuron

See all news